Added value of molecular karyotype in childhood acute lymphoblastic leukemia

Cancer Innovation Pub Date : 2023-06-01 DOI:10.1002/cai2.67
Margaux Camuset, Baptiste Le Calvez, Olivier Theisen, Catherine Godon, Audrey Grain, Caroline Thomas, Marie-Laure Couec, Marie C. Béné, Fanny Rialland, Marion Eveillard
{"title":"Added value of molecular karyotype in childhood acute lymphoblastic leukemia","authors":"Margaux Camuset,&nbsp;Baptiste Le Calvez,&nbsp;Olivier Theisen,&nbsp;Catherine Godon,&nbsp;Audrey Grain,&nbsp;Caroline Thomas,&nbsp;Marie-Laure Couec,&nbsp;Marie C. Béné,&nbsp;Fanny Rialland,&nbsp;Marion Eveillard","doi":"10.1002/cai2.67","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Thanks to an improved therapeutic regimen in childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL), 5 year-overall survival now exceeds 90%. Unfortunately, the 25% of children who relapse have an initial poor prognosis, potentially driven by pre-existing or emerging molecular anomalies. The latter are initially and essentially identified by cytogenetics. However, some subtle alterations are not visible through karyotyping.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Single nucleotide polymorphisms (SNP) array is an alternative way of chromosomal analysis allowing for a more in-depth evaluation of chromosomal modifications such as the assessment of copy number alterations (CNA) and loss of heterozygosity (LOH). This method was applied here in retrospective diagnosis/relapse paired samples from seven children with BCP-ALL and in a prospective cohort of 38 newly diagnosed childhood cases.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>In the matched study, compared to the initial karyotype, SNP array analysis reclassified two patients as poor prognosis cases. Modulation during relapse was seen for 4 CNA and 0.9 LOH. In the prospective study, SNP reclassified the 10 patients with intermediate karyotype as 7 good prognosis and 3 poor prognosis. Ultimately, in all the children tested, SNP array allowed to identify additional anomalies compared to conventional karyotype, refine its prognostic value and identify some druggable anomalies that could be used for precision medicine. Overall, the anomalies detected could be segregated in four groups respectively involved in B-cell development, cell proliferation, transcription and molecular pathways.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>SNP therefore appears to be a method of choice in the integrated diagnosis of BCP ALL, especially for patients initially classified as intermediate prognosis. This complementary method of both cytogenetics and high throughput sequencing allows to obtain further classified information and can be useful in case of failure of these techniques.</p>\n </section>\n </div>","PeriodicalId":100212,"journal":{"name":"Cancer Innovation","volume":"2 6","pages":"513-523"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cai2.67","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Innovation","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cai2.67","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Thanks to an improved therapeutic regimen in childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL), 5 year-overall survival now exceeds 90%. Unfortunately, the 25% of children who relapse have an initial poor prognosis, potentially driven by pre-existing or emerging molecular anomalies. The latter are initially and essentially identified by cytogenetics. However, some subtle alterations are not visible through karyotyping.

Methods

Single nucleotide polymorphisms (SNP) array is an alternative way of chromosomal analysis allowing for a more in-depth evaluation of chromosomal modifications such as the assessment of copy number alterations (CNA) and loss of heterozygosity (LOH). This method was applied here in retrospective diagnosis/relapse paired samples from seven children with BCP-ALL and in a prospective cohort of 38 newly diagnosed childhood cases.

Results

In the matched study, compared to the initial karyotype, SNP array analysis reclassified two patients as poor prognosis cases. Modulation during relapse was seen for 4 CNA and 0.9 LOH. In the prospective study, SNP reclassified the 10 patients with intermediate karyotype as 7 good prognosis and 3 poor prognosis. Ultimately, in all the children tested, SNP array allowed to identify additional anomalies compared to conventional karyotype, refine its prognostic value and identify some druggable anomalies that could be used for precision medicine. Overall, the anomalies detected could be segregated in four groups respectively involved in B-cell development, cell proliferation, transcription and molecular pathways.

Conclusion

SNP therefore appears to be a method of choice in the integrated diagnosis of BCP ALL, especially for patients initially classified as intermediate prognosis. This complementary method of both cytogenetics and high throughput sequencing allows to obtain further classified information and can be useful in case of failure of these techniques.

Abstract Image

儿童急性淋巴细胞白血病分子核型的附加值
背景 由于儿童 B 细胞前体急性淋巴细胞白血病(BCP-ALL)治疗方案的改进,目前 5 年总生存率已超过 90%。不幸的是,25%的复发患儿最初预后较差,这可能是由已经存在或新出现的分子异常引起的。后者最初基本上是通过细胞遗传学确定的。然而,有些微妙的改变在核型检查中并不明显。 方法 单核苷酸多态性(SNP)阵列是染色体分析的另一种方法,可以更深入地评估染色体的改变,如评估拷贝数改变(CNA)和杂合性缺失(LOH)。本文将这种方法应用于 7 名 BCP-ALL 儿童的回顾性诊断/复发配对样本和 38 例新诊断儿童病例的前瞻性队列。 结果 在配对研究中,与初始核型相比,SNP 阵列分析将两名患者重新归类为预后不良病例。4 例 CNA 和 0.9 例 LOH 在复发过程中发生了改变。在前瞻性研究中,SNP 将 10 例中等核型患者重新分类为 7 例预后良好和 3 例预后不良。最终,与传统核型相比,SNP 阵列可在所有受测儿童中发现更多异常,完善其预后价值,并发现一些可用于精准医疗的药物异常。总体而言,检测到的异常可分为四组,分别涉及 B 细胞发育、细胞增殖、转录和分子通路。 结论 因此,SNP 似乎是 BCP ALL 综合诊断的首选方法,尤其是对于最初被归类为中等预后的患者。这种细胞遗传学和高通量测序的互补方法可以获得更多的分类信息,并在这些技术失效时发挥作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.70
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信